Clinical Pharmacy Centanafadine: A Revolution in ADHD Treatment? Centanafadine (Simtriyo), a first-in-class NDSRI for ADHD, offers a new treatment approach but carries important safety and abuse warnings.
Apothecary’s Apprentice Apothecary’s Apprentice: The Surprising Origins of Metformin Metformin’s plant-based origins and rise to prominence reveal why it became the only biguanide widely used in diabetes care today.
Clinical Pharmacy DOACs for Venous Thromboembolism: Which is the Best? A practical comparison of DOACs for VTE, covering indications, dosing, bleeding risk, renal considerations, and reversal.
Apothecary’s Apprentice Apothecary’s Apprentice: The Secrets of Senna A pharmacist's guide to senna: its origins, clinical uses, safety considerations, and comparison to other laxatives.
Clinical Pharmacy New Oral GLP-1 Orforglipron Receives FDA Approval FDA-approved orforglipron is the first oral non-peptide GLP-1, offering weight loss and glycemic control without injections.
Science The Return of Ranitidine Ranitidine (Zantac) returns after NDMA-related recall, with reformulation aimed at improving safety while maintaining GERD treatment efficacy.
Clinical Pharmacy The Anti-Smoking Antidepressant Bupropion’s dopamine and norepinephrine effects reduce nicotine cravings, explaining its FDA approval as a first-line smoking cessation aid now.
Clinical Pharmacy Hypervolemic Hyponatremia Hyponatremia in hypervolemic patients explained: risks in older adults, safe sodium correction, and treatment options including loop diuretics and vaptans.